Background And Objectives: Diamond Blackfan anemia (DBA) is a congenital disease characterized by defective erythroid progenitor maturation. Patients' bone marrow progenitor cells do not respond to erythropoietic growth factors, such as erythropoietin. Mutations in the gene encoding for ribosomal protein (RP) S19 account for 25% of cases of DBA. The link between defective erythropoiesis and RPS19 is still unclear. Two not mutually exclusive hypotheses have been proposed: altered protein synthesis and loss of unknown extraribosomal functions.
Design And Methods: We used yeast two-hybrid screening and a human liver cDNA library obtained at 19-24 weeks of gestation, when hepatic erythropoiesis is efficient, to search for proteins interacting with RPS19.
Results: We found that RPS19 binds PIM-1, an ubiquitous serine-threonine kinase whose expression can be induced in erythropoietic cells by several growth factors, such as erythropoietin. The PIM-1/RPS19 interaction was demonstrated both in vitro and in living cells and led to phosphorylation of RPS19 in an in vitro kinase assay. We also showed that in human 293T cells PIM-1 interacts with ribosomes and may be involved in translational control. Three DBA-associated RPS19 mutations alter the binding between RPS19 and PIM-1.
Interpretation And Conclusions: A link between erythropoietic growth factor signaling and RPS19 has been identified for the first time.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Erythropoietin and glial cells in central and peripheral nervous systems.
Mol Biol Rep
October 2024
Department of Physiology and Pharmacology, Afzalipour School of Medicine, Kerman University of Medical Sciences, Kerman, Iran.
Article Synopsis
- Erythropoietin (EPO) is primarily used to treat anemia and also acts as a neuroprotective agent in the central nervous system by binding to its receptor, EPOR, on neurons and glial cells.
- The EPO-EPOR complex initiates specific signaling pathways in glial cells that may influence various neurological disorders, including Alzheimer's, Parkinson's, and conditions like stroke and trauma.
- The review emphasizes EPO's role across different glial cell types and suggests that understanding its non-blood-related actions could improve treatments for CNS disorders and highlight its neuroprotective capabilities.
Renal protective effects of helix B surface polypeptide in rats with puromycin aminonucleoside nephropathy.
Ren Fail
December 2024
Division of Nephrology, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China.
Background: Recent studies have reported that helix B surface polypeptide (HBSP), an erythropoietin derivative, exhibits strong tissue protective effects, independent of erythropoietic effects, in a renal ischemia-reperfusion (IR) injury model. Meanwhile, the transforming growth factor-β (TGF-β) superfamily member glial cell line-derived neurotrophic factor (GDNF) demonstrated protective effect on podocytes . Using a rat puromycin aminonucleoside nephropathy (PAN) model, this study observed the renal protective effect of HBSP and investigated its renal protective effect on podocytes and mechanism related to GDNF.
View Article and Find Full Text PDFAn overview of benefits and risks of chronic melanocortin-1 receptor activation.
J Eur Acad Dermatol Venereol
January 2025
Wellcome-MRC Institute of Metabolic Science, Addenbrooke's Hospital, University of Cambridge Metabolic Research Laboratories and NIHR Cambridge Biomedical Research Centre, Cambridge, UK.
Article Synopsis
- The melanocortin-1 receptor (MC1R) is crucial for skin pigmentation and regulates various processes like melanin production and inflammation.
- Loss-of-function variants of MC1R can impair its activity, leading to health issues, while chronic activation can be triggered by conditions such as Addison's disease and UV radiation exposure.
- New drugs that target MC1R are being developed for conditions like obesity and skin protection, and while enhanced pigmentation may offer some UV protection, it doesn't completely prevent melanoma, emphasizing the importance of regular skin checks for at-risk individuals.
Extracellular vesicles originating from melanoma cells promote dysregulation in haematopoiesis as a component of cancer immunoediting.
J Extracell Vesicles
July 2024
Biomolecular and Cellular Medicine (BCM), Department of Laboratory Medicine, Karolinska Institutet, Huddinge, Sweden.
Haematopoiesis dysregulation with the presence of immature myeloid and erythroid immunosuppressive cells are key characteristics of the immune escape phase of tumour development. Here, the role of in vitro generated B16F10 tumour cell-derived extracellular vesicles (tEVs) as indirect cellular communicators, participating in tumour-induced dysregulation of haematopoiesis, was explored. The isolated tEVs displayed features of small EVs with a size range of 100-200 nm, expressed the common EV markers CD63, CD9, and Alix, and had a spherical shape with a lipid bilayer membrane.
View Article and Find Full Text PDFIron Absorption: Molecular and Pathophysiological Aspects.
Metabolites
April 2024
Department of Biomedical Sciences for Health, University of Milan, 20133 Milan, Italy.
Iron is an essential nutrient for growth among all branches of life, but while iron is among the most common elements, bioavailable iron is a relatively scarce nutrient. Since iron is fundamental for several biological processes, iron deficiency can be deleterious. On the other hand, excess iron may lead to cell and tissue damage.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!